Published in Eur J Endocrinol on February 01, 2002
Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest (2005) 3.92
Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol (2006) 3.61
Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A (2004) 2.91
Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes (2010) 2.01
Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology (2007) 1.64
Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut (2005) 1.60
Ghrelin. Mol Metab (2015) 1.29
Ghrelin in central neurons. Curr Neuropharmacol (2009) 1.17
Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Mol Endocrinol (2011) 1.13
Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia (2008) 1.09
Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology (2009) 1.04
Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci U S A (2012) 1.02
Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes (2014) 0.98
IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A (2006) 0.97
Modulation of ghrelin O-acyltransferase expression in pancreatic islets. Cell Physiol Biochem (2010) 0.97
Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells. Diabetes (2011) 0.94
Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol (2012) 0.93
Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. Mol Metab (2016) 0.90
The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Sci Rep (2015) 0.89
Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88
Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications. Int J Pept (2010) 0.88
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol (2003) 0.87
Final answer: ghrelin can suppress insulin secretion in humans, but is it clinically relevant? Diabetes (2010) 0.84
Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice. Diabetologia (2012) 0.82
The Beginnings of Pancreatology as a Field of Experimental and Clinical Medicine. Biomed Res Int (2015) 0.82
Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists. Int J Pept (2010) 0.80
Ghrelin and eating disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.80
Breast milk hormones and regulation of glucose homeostasis. Int J Pediatr (2011) 0.78
Relationships between acylated ghrelin with growth hormone, insulin resistance, lipid profile, and cardio respiratory function in lean and obese men. J Res Med Sci (2011) 0.77
Serum Insulin Levels Are Reduced by Intravenous Ghrelin Administration but Do Not Correlate with Alcohol Craving in Alcohol-Dependent Individuals. Int J Neuropsychopharmacol (2016) 0.75
Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy. PLoS One (2016) 0.75
Endogenous somatostatin is critical in regulating the acute effects of L-arginine on growth hormone and insulin release in mice. Endocrinology (2013) 0.75
Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects. Br J Clin Pharmacol (2016) 0.75
Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice. Front Endocrinol (Lausanne) (2017) 0.75
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1993) 6.52
The impact of weekends on outcome for acute exacerbations of COPD. Eur Respir J (2011) 2.40
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access. Eur Heart J (2000) 2.13
Nocturnal oximetry for the diagnosis of the sleep apnoea hypopnoea syndrome: a method to reduce the number of polysomnographies? Thorax (1999) 1.95
Large glucagon immunoreactivity in extracts of pancreas. J Biol Chem (1970) 1.70
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE). J Thromb Haemost (2005) 1.53
In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol (2000) 1.49
Coronary stenting in diabetics: immediate and mid-term clinical outcome. Catheter Cardiovasc Interv (1999) 1.48
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease. Catheter Cardiovasc Interv (2000) 1.41
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol (1995) 1.40
[Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome]. Arch Bronconeumol (1999) 1.30
Characterization of glucagon-like immunoreactivity (GLI). Diabetes (1970) 1.29
Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol (2001) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue. Endoscopy (2002) 1.22
Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med (1973) 1.22
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Corynebacterium mastitidis sp. nov., isolated from milk of sheep with subclinical mastitis. Int J Syst Bacteriol (1997) 1.15
Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma. Diabetes (1970) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
[Deficiency, disability and handicap in multiple sclerosis: a population-based study in Valladolid]. Rev Neurol (1998) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med (1973) 1.07
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Preparatory visuo-motor cortical network of the contingent negative variation estimated by current density. Neuroimage (2003) 1.05
[Sedation in digestive endoscopy. Results of a hospital survey in Catalonia (Spain)]. Gastroenterol Hepatol (2004) 1.04
Molecular typing by pulsed-field gel electrophoresis of Spanish animal and human Listeria monocytogenes isolates. Appl Environ Microbiol (2001) 1.02
Human coronary laser recanalization. Clin Cardiol (1984) 1.02
Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation (1996) 1.02
Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon"). J Clin Endocrinol Metab (1974) 1.00
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies. Heart (2005) 0.95
Intracoronary stent implantation: new approach using a monorail system and new large-lumen 7F catheters from the brachial route. Cathet Cardiovasc Diagn (1992) 0.95
Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol (1997) 0.95
Effect of endogenous intestinal glucagon-like immunoreactivity (GLI) on insulin secretion and glucose concentration in dogs. J Clin Endocrinol Metab (1971) 0.95
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95
Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine (2009) 0.94
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol (1995) 0.94
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Aseptic meningitis and focal central nervous system involvement in a case of adult onset Still's disease. J Rheumatol (1993) 0.90
A direct plating method for monitoring the contamination of Listeria monocytogenes in silage. Zentralbl Veterinarmed B (1992) 0.90
Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas. Horm Metab Res (2001) 0.90
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept (1993) 0.89
Long-term (> or =8 years) outcome after Palmaz-Schatz stent implantation. Am J Cardiol (2001) 0.89
The glycogenolytic activity of immunoreactive pancreatic glucagon in plasma. J Clin Invest (1971) 0.89
Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas. J Endocrinol (2008) 0.88
Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and gluconeogenesis in isolated rat hepatocytes: antagonism by insulin. Endocrinology (1983) 0.87
Results of stenting of unprotected left main coronary artery stenosis in patients at high surgical risk. Am J Cardiol (1998) 0.87
Lercanidipine in patients with chronic renal failure: the ZAFRA study. Ren Fail (2005) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro. Endocrinology (1987) 0.86
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2011) 0.85
Cis-diaminedichloro platinum ototoxicity. An experimental study. Acta Otolaryngol (1985) 0.85
Search for three-jet resonances in pp collisions at square root(s)=7 TeV. Phys Rev Lett (2011) 0.85
[Obstructive sleep apnea syndrome in the Community of Valencia: current situation, study of needs and future prospects]. Arch Bronconeumol (1998) 0.85
Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet (2013) 0.85
Observation of sequential Υ suppression in PbPb collisions. Phys Rev Lett (2012) 0.84
Plasma glucagon immunoreactivity in a totally pancreatectomized patient. Diabetologia (1976) 0.84
Efficacy of three drugs for protecting against gentamicin-induced hair cell and hearing losses. Br J Pharmacol (2012) 0.84
Ultrastructural study of the human utricular macula and vestibular nerve in meniére's disease. Acta Otolaryngol (1975) 0.84
Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept (1990) 0.83
Hypotensive anaesthesia and bleeding during endoscopic sinus surgery: an observational study. Eur Arch Otorhinolaryngol (2013) 0.83
Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas. Eur J Pharmacol (2003) 0.83
Simultaneous obstructing and pseudomembranous necrotizing tracheobronchitis due to Aspergillus flavus. Clin Infect Dis (1998) 0.82
Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab (1980) 0.82
"High-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation. Cathet Cardiovasc Diagn (1990) 0.82
Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain). J Hum Hypertens (2005) 0.82
Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. Horm Metab Res (1983) 0.81
Exendin-4 dose-dependently stimulates somatostatin and insulin secretion in perfused rat pancreas. Horm Metab Res (2004) 0.81
[Complications of transluminal coronary angioplasty. A multicenter French study (1983)]. Arch Mal Coeur Vaiss (1985) 0.81
Study of Z Boson Production in PbPb Collisions at √S(NN)=2.76 TeV. Phys Rev Lett (2011) 0.81
Inhibitory effect of galanin on pancreatic polypeptide release by the perfused rat pancreas. Life Sci (1987) 0.81
Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation (1994) 0.81
Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results. J Am Coll Cardiol (1992) 0.81
Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat. Biochem Biophys Res Commun (1986) 0.81
Dijet azimuthal decorrelations in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.80
Glucagon-releasing activity of guanidine compounds in mouse pancreatic islets. FEBS Lett (1976) 0.80
1997 spanish nephrology association (Sociedad Española de nefrologia) report on dialysis and transplantation. Nephrol Dial Transplant (1999) 0.80
Ultrastructure of the otoliths and otolithic membrane of the macula utriculi in the guinea pig. Acta Otolaryngol (1971) 0.80
Potentiation of glucagon secretion by serotonin antagonists in man. J Clin Endocrinol Metab (1976) 0.80
[Chylothorax as presenting form of a gastric adenocarcinoma]. Rev Esp Enferm Dig (1996) 0.80